期刊文献+

醛固酮受体拮抗剂在预防心房颤动复发中的作用及对心房重构的影响 被引量:6

Efficacy of Aldosterone Antagonists in Preventing Atrial Fibrillation Recurrence and Atrial Remodeling
下载PDF
导出
摘要 目的探讨醛固酮受体拮抗剂(螺内酯)在心房颤动恢复窦性心律后预防其复发,对窦性心律有效性的维持以及对心房重构的影响。方法 80例持续性房颤患者(持续超过7天),经药物或电复律后随机分为两组,对照组40例给予胺碘酮0.2 g,每日1次,治疗组40例给予胺碘酮0.2 g,每日1次,醛固酮受体拮抗剂螺内酯40 mg,1次/日,两组均连续服用6个月。于治疗后第1周、2周、1月、2月、4月及6月分别行心电图或HOLTER以检测是否存在房颤复发;复律次日及6月后做超声心动图检查,观察左心房结构及功能变化。随访6个月,观察研究前后血浆醛固酮(aldosterone,Ald)浓度。结果 80例均完成治疗,随访6月,心房颤动复发率对照组32.5%,治疗组12.5%,两组间比较有统计学意义(P<0.05)。治疗组心房颤动转复6月后患者左心房内径缩小,左房射血分数(LAEF)增高。治疗前后比较差异有统计学意义(P<0.05);对照组患者治疗前、治疗后比较差异无统计学意义(P>0.05)。结论持续性心房颤动复律后,为了维持窦性心律,联合应用胺碘酮、螺内酯较单独应用胺碘酮更加有效,螺内酯的长期服用可缩小扩大的左房,左房压力降低,对肾素-血管紧张素-醛固酮系统激活的抑制可改善心房重构,预防房颤反复复发。 Objective To evaluate the efficacy of Aldosterone antagonist in maintenance of sinus rhythm after cardiover- sion of atrial fibril lation and its influence on atrial function. Methods 80 patients with persistent atrial fibril lation were randomly divided into two groups, after cardioversion using either antiarrhythmie medicines or synchronized direct current. Two groups of patients were compared. Control group was treated with amiodarone 0. 2 g daily for 6 month, management group was treated with amiodarone 0.2 g daily plus Aldosterone antagonist (Spironolaetone) 40 mg daily in the same pe- riod. During 6 month of follow - up, electrocardiogram and 24 - hour holter recording were performed for detection of re- currence of AF in the first week, second week, first month, second month, fourth month and sixth month. The echocar- diography examinations were performed on the next day and six months after eardioversion to evaluate changes in left atri- al structure and function. Results After 6 month of follow - up , there were 32. 5% AF recurrence of control group while 12. 5% with AF recurrence of management group. There was a significant difference between the two groups (P 〈 0. 05 ), the left atrial diameter (LAD, mm) measured by echocardiography on the next day and six months after cardio- version in management group was reduction ( P 〈 0.05 ) , while in control group, LAD did not show any significant reduc- tion after six months (P 〉 0.05 ). Conclusions Combination of Aldosterone antagonist and amiodarone is more effective in maintenance of sinus rhythm after cardioversion of AF than amiodarone alone. Long term treatment of Aldosterone an- tagonist may reverse LA enlargement, decrease LA pressure and prevent the recurrence of AF.
作者 夏立志 张莉
出处 《航空航天医学杂志》 2013年第12期1450-1452,共3页 Journal of Aerospace medicine
关键词 醛固酮受体拮抗剂 心房颤动 心房重构 aldosterone antagonists atrial fibrillation atrial remodeling
  • 相关文献

参考文献16

  • 1王学东,贾三庆,胡大一,吴永全,邢云丽,陈金玲,杜立杰.心房颤动患者循环血浆肾素、血管紧张素Ⅱ和醛固酮的变化及临床意义[J].中国心血管杂志,2004,9(5):339-341. 被引量:25
  • 2刘微微,沃金善,李波.瑞舒伐他汀联用胺碘酮在心房颤动电复律后维持窦性心律中的作用[J].实用医学杂志,2010,26(14):2622-2623. 被引量:7
  • 3陈平安,刘震,李韶南.血管紧张素转换酶及脑利钠肽与心房颤动关系的临床分析[J].实用医学杂志,2009,25(14):2267-2269. 被引量:7
  • 4LITTLE WC,ZILE MR,KITZMAN dw. The effect of alagebrium chloride ALT-711 a novel glucose cross-link breaker in the treatment of elderly patients with diastolic heart failure[J].{H}Journal of Cardiac failure,2005,(03):191-195. 被引量:1
  • 5ALLESSIE MA,BOYDEN PA,CAMM aj. Pathophysiology and prevention of atrial fibrillation[J].Circulation,2001,(05):769-777. 被引量:1
  • 6Sanders P,Morton JB,Davidson NC. Electrical remodeling of the at riain congestive heart failure:electrophysiol ogical and el ectroanatomi cmapping in humans[J].{H}CIRCULATION,2003,(12):1461-1468. 被引量:1
  • 7Cha T J,Ehrlich JR,Zhang L. Diss ociation between ionic remodeling an d ability to sustain at rial fibrillation during recovery from experimental congestive heart failure[J].{H}CIRCULATION,2004,(03):412-418. 被引量:1
  • 8Xu J,Cui G,Esmailian F. At rialex tracellular matrix remodeling and the main tenance of at rial fibrillation[J].{H}CIRCULATION,2004,(03):363-368. 被引量:1
  • 9TOPS LF,BAX JJ,ZEPPENFELD K. Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size[J].{H}American Journal of Cardiology,2006,(08):1220-1222. 被引量:1
  • 10Boldt A,Wetzel U,Weigl J. Ex pres sion of angioten sinrecept ors in human l ef tan d right at rial tissue in at rial fibrillation w ith and without underlying mitral valve disease[J].{H}Journal of the America College of Cardiology,2003,(10):1785-1792. 被引量:1

二级参考文献46

  • 1王学东,贾三庆,胡大一,吴永全,邢云丽,陈金玲,杜立杰.心房颤动患者循环血浆肾素、血管紧张素Ⅱ和醛固酮的变化及临床意义[J].中国心血管杂志,2004,9(5):339-341. 被引量:25
  • 2胡大一,孙艺红.心房颤动的流行病学和治疗现状[J].中华全科医师杂志,2006,5(1):5-7. 被引量:85
  • 3裴德安,李莉.心房颤动总是“引发”心房颤动吗?[J].国际心血管病杂志,2006,33(3):166-169. 被引量:3
  • 4Nakashima H,Kumagai K,Urate H,et al.Angiotensin Ⅱ antagonist prevents electrical remodelling in atrial fibrillation[J].Circulation,2000,101 (22):2612-2617. 被引量:1
  • 5Madrid A H,Peng J,Zamora J,et al.The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases meta-analysis of randomized controlled clinical trials[J].Pacing Clin Electrophysiol,2004,27(10):1405-1410. 被引量:1
  • 6Tuinenburg A E,Brundel B J,et al.Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation[J].J Cardiovasc Electrophysiol,1999,10(6):827-835. 被引量:1
  • 7Goette A,Staack T,Rocken C,et al.Increased expression of extracellular signate regulated kinase and angiotension-converting enzyme in human atria during atrial fibrillation[J].J Am Coll Cardiol,2000,35(6):1669-1977. 被引量:1
  • 8Li P,Chen P M,Wang S W,et al.Time-dependent expression of chymase and angiotensian converting enzyme in the hamster heart underpressure overload[J].Hypertens Res,2002,25 (5):757. 被引量:1
  • 9Tsuchida K,Tanabe K.Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion[J].J Cardiol,2004,44(1):1-11. 被引量:1
  • 10Kim B G,Hwang S J,Sung K C.Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function[J].J Cardiol 2007,118(2):145-150. 被引量:1

共引文献39

同被引文献65

  • 1冯惠清,崔炜,冯惠平,单保恩.醛固酮对新生大鼠心肌成纤维细胞分泌ET、NO功能的影响[J].中国应用生理学杂志,2005,21(1):78-80. 被引量:10
  • 2孙艺红,胡大一.非瓣膜病心房颤动转复窦性心律复发影响因素的研究[J].中国心脏起搏与心电生理杂志,2005,19(3):172-174. 被引量:29
  • 3European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the managemrnt of atrial fibrillation: The Task Force for the Man- agement of Atrial Fibrillation of the European Society of Cardiol ogy (ESC)[J]. Eur Heart J, 2010, 31 (19): 2369-2429. 被引量:1
  • 4January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrilla- tion: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [J]. J Am Coll CardioI, 2014, 64 (21): e1-e76. 被引量:1
  • 5Goette A, Haffmanns P, Enayati W, et al. Effect of successful electrical cardioversion on serum aldosterone in patients with per- sistent atrial fibrillation [J]. Am J Cardiol, 2001, 88 (8): 906 -909, A8. 被引量:1
  • 6Berglund H, Boukter S, Theodorsson E, et al. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation [J]. Br Heart J, 1990, 64 (1): 9-13. 被引量:1
  • 7Benitah JP, Pettier E, G6mez AM, et al. Effects of aldoste- rone on transient outward K+ current density in rat ventricular myocytes [J]. J Plysiol, 2001, 537 (Ptl): 151-160. 被引量:1
  • 8Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation [J]. J Am Coll Cardiol, 2008, 51 (8): 802-809. 被引量:1
  • 9陈明龙.心力衰竭与室性心律失常[J].中华心律失常学杂志,2008,12(1):59-62. 被引量:17
  • 10刘伟利,王桂芳.螺内酯联合胺碘酮治疗非瓣膜病阵发性心房颤动的临床研究[J].中国心血管病研究,2008,6(10):764-766. 被引量:6

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部